Clinical Pharmacy 2023 | Prague | Czech Republic | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Improving Healthcare Through Innovative Clinical Pharmacy Practice

- Clinical Pharmacy 2023

Welcome Message

We warmly welcome from all over the world to attend the conference entitled “The 3rd International Conference on Clinical Pharmacy and Clinical Research” scheduled during February 13-15, 2023, which is going to be held in Rome, Italy.

Clinical Pharmacy 2023 may serve as a global forum for debating, exchanging, and exploring new fields of research and development as well as for learning about emerging technologies and algorithms in clinical research and clinical pharmacy.

Clinical Pharmacy 2023 would be a fantastic chance to learn more about pharmacy-related topics and gain practical experience. A group of worldwide leaders in the developing pharmacy practise sectors will be gathered at this international conference.

The program includes keynote addresses, lectures, interactive workshops, poster presentations, and exhibitions.

Keep in touch with us throughout Clinical Pharmacy 2023 to help us stay proactive and help Clinical Pharmacy's future take form.

We Look forward to your presence in Rome, Italy

Best regards

Organizing Committee

Clinical Pharmacy 2023

About Conference

On the behalf of organizing the committee, we would like to extend an invitation to join us for the conference on “3rd International Conference onClinical PharmacyandClinical Research”which is scheduled to commence on Feb 13-15, 2023, in Rome, Italy.

This year'sClinical Pharmacy2023 is expected to be two days of interactive, stimulating discussions with 10+ keynote lectures, 50+ plenary lectures, 10+ Young Investigator Forum lectures, and 20+ poster sessions, in addition, there are no less than 3 workshops and then 2 symposiums.

We also plan to offer a number of technical demonstrations and informal networking opportunities.

Why Clinical Pharmacy 2023?

Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, andClinical Pharmacyreceives name recognition at this 2-day event. This conference is packed with world-renowned speakers who are experts inPharmacovigilance. They're sharing the latest techniques, developments, and the newest updates on this important field.

A platform to promote your ideology and ensure its value Communicate and communicate with colleagues and superiors Collaboration, Career development, etc. In addition, it offers the greatest multidisciplinary forum for pharmacists, medical professionals, researchers, practitioners, and young achievers to attend the event and discuss workable problems and answers related to Pharmacists should be aware of the latest advances, trends, and concerns in the field.

A platform to promote your ideology and ensure its value Communicate and communicate with colleagues and superiors Collaboration, Career Development, Personal communication that leads to an optimistic future Getting out of your comfort zone is never easy, introspection speech presentation.

A platform to express your ideology and guarantee its value
Collaborations, Career Development, Personal interaction that leads to an optimistic future
Breaking your comfort zone is never easy, presenting speeches directing to Self-analysis

Benefits of Attending:

Research scientists, professors, medical professionals, business entrepreneurs, and research scholars from all over the world will be present atClinical pharmacy2023 for discussing their knowledge and views for the betterment ofPharmacyandresearch.

Get feedback on early drafts of your latest work
Get to know others in your field
Discover the latest research
Improve your presentation and communication skills
Visit a new place and have fun
Meet your academic heroes
Learn beyond your field of interest

For Business Delegates:

Access to all Sessions
Handbook & Conference Kit
Book Launch event
Networking opportunities
Certificate of Presentation
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
The network of Young Researchers (YRF Award for Best Presenter)
Student Attendee

Who to attend?

Directors, CEO’s of Organizations
Business Development Managers
Chief Scientific Officers
Professors, Associate Professors, Assistant Professors
Ph.D. Scholars
Patent Attorneys
Intellectual Property Attorneys
Investment Analysts
Association, Association presidents and professionals
Drug development and discovery companies
Medical technology companies
Universities and institutes
Clinical Pharmacy and Clinical Research Companies
Intellectual property and legal organizations
Investors and financial services providers
Bio-clusters and incubators
Government and public support agencies
Cosmetic companies

Sessions & Tracks

Session 1: Clinical pharmacy

Clinical pharmacy mainly focuses on considering people's needs for drugs, administrative routes, modes of use, effects of drugs on patients, and overall management of drug treatment. General clinical pharmacy requires knowledge in several parts such as knowledge of drug therapy, understanding of diseases, proficiency in the laboratory and diagnostic skills, acquisition of patient monitoring skills, awareness of drug information skills, and therapy planning skills.

Related Associations:

International Pharmaceutical Federation (FIP) | National Association of Boards of Pharmacy (NABP) | International Pharmaceutical Students' Federation (IPSF) | National Community Pharmacists Association (NCPA) | Non-prescription Drug Manufacturers Association of Canada (NDMAC) | Association of the British Pharmaceutical Industry (ABPI) | American Association of Colleges of Pharmacy (AACP) | California Pharmacists Association (CPhA) | Canadian Pharmaceutical Association | International Association for Pharmaceutical Technology | Nonprescription Drug Manufacturers Association (NDMA) | National Pharmaceutical Association (NPA) | Serbian Medical Association, Section of Clinical Pharmacology

Associated Journal

Journal of Oncology Practice | Indian journal of Pharmaceutical sciences | Systematic Reviews in Pharmacy | Biomedical and Pharmacology Journal | Journal Of Pharmaceutical And Biological Sciences | Journal of medical Pharmaceutical and allied sciences | American journal of forensic medicine and pathology | IP International Journal of Forensic Medicine and Toxicological Sciences | Journal of Forensic Medicine | The Asian Journal of Pharmaceutical and clinical research | International Journal of Pharmacy and Pharmaceutical Sciences | International Journal of Pharma and Bio Sciences | International journal of clinical pharmacy

Associated Societies

American Society of Health-System | European Society of Clinical Pharmacy | South African Society of Clinical Pharmacy | Swedish Society for Pharmacology, Clinical Pharmacology and Therapeutics | Spanish Society of Clinical Pharmacology | Korean Society for Clinical Pharmacology | Japanese Society of Clinical Pharmacology and Therapeutics | American Chemical Society (ACS) | Pharmaceutical Society of Australia (PSA) | Controlled Release Society (CRS) | Canadian Society for Pharmaceutical Sciences (CSPS) | American Chemical Society Division of Medicinal Chemistry

Session 2: Pharma Research and Development

Drug development is the way to bring a new drug to market when the lead compound has been recognized through drug discovery. This includes preclinical research in microorganisms and organisms, applying for regulatory status for example, through the U.S. Food and Drug Administration for an investigative new drug to start human clinical trials and possibly incorporate regulatory approval processes with a quiet new application for drug advertising.

Related Associations:

Associated Journal

Associated Societies

Session 3: Clinical pharmacy and pharmacy practice

Clinical pharmacy and Pharmacy practice play an important role in clinical trials and clinical research. In recent years, the role of Pharmacists in clinical research and patient care has improved significantly, and they play an active role in the design and regulation of drug therapies. This session focuses on recent advances in Clinical Research and Pharmaceutical practice.

Related Associations:

Associated Journal

Associated Societies

Session 4: Clinical Pharmacology and Toxicology

Clinical pharmacology bridges the relationship between medical practice and laboratory science. The main goal is to enhance the safety of the prescription, maximize the effect of the drug, and minimize its side effects of the drug. It is important to have associations with pharmacists who are competent in the areas of drug information, drug safety and other aspects of pharmacy practice related to clinical pharmacy. Clinical pharmacologists must have access to enough outpatients for clinical care, teaching, and education, and researchers shall be supervised by medical professionals.

The scope of oncology research is often high, and the complexity of clinical trial designs and study designs is increasing. Reports currently show that the success rate of investigational compounds approved for clinical use in cancer is the lowest of any disease, and only 6.7% are thought to be approved for these diseases. Cancer drugs are being studied in Phase I studies. In oncology, there are key differences in clinical trials.

Related Associations:

Associated Journal

Associated Societies

Session 6: Drug Discovery in Preclinical Research

In the fields of medicine, biotechnology, and Pharmacology, drug discovery is the process by which new drug candidates are discovered through rigorous studies.. Historically, drugs were discovered by identifying active ingredients from traditional remedies or discovered by accident, such as Penicillin. Pre-clinical research leading to clinical trials

Related Associations:

Associated Journal

Associated Societies

Session 7: Pharmaceutical Cell Biology

Cell biologists may also become more involved in the clinical development of new and reference drugs, particularly with regard to indications, diagnostic development, and population stratification. . In this case, it is valuable to know more about the clinical stages of drug development.

Related Associations:

Associated Journal

Associated Societies

Session 8: Pharmacoepidemiology

Pharmacoepidemiology is the study of the use and effects of drugs in a large number of people it provides an estimate of the probability of a drug's beneficial effects occurring in a population and the probability of side effects occurring. It can be called a bridging science that includes both clinical pharmacology and epidemiology.

Related Associations:

Associated Journal

Associated Societies

Session 9 : Pharmacovigilance and Pharmacoeconomics

Pharmacovigilance is the science and activities related to the detection, evaluation, understanding and prevention of side effects or any other drug/vaccine related problem. Pharmaceutical economics refers to the field of science that compares the value of one drug or drug treatment with another.

Related Associations:

Associated Journal

Associated Societies

Session 10: Healthcare and Patient safety

Patient safety is the prediction of adverse patient outcomes related to surveillance and health. Health has proven to be more effective, but it has also been shown to become easier as new innovations, drugs and coatings become more widely used. Health officials dealing often with serious comorbidities, are seeking increasingly uncomfortable medical options. Increased financial burden on health care providers often leads to situations of health care overload. Patient safety can become an issue that emphasizes medical safety through the prevention, minimization, reporting, and investigation of recovery impairment, which often has a hostile impact.

Related Associations:

Associated Journal

Associated Societies

Session 11: Clinical Pharmacology and Toxicology

Pharmacy toxicology is the study of the adverse effects to exposure a drugs and other prescription items in the medical industry. Treatment and prevention of disorders brought by pharmaceuticals are also included in the field of pharmacy toxicology. The chemical modification of a chemical produced by a creature as well as mineral compounds like CO2, NH4 +, or H2O is known as bio transformation. It is a chemical change known as biotransformation which occurs when medications, poisons, nutrients, and amino acids are all present in the body. If a medicine attaches to unanticipated proteins, receptors, or enzymes that could alter pathways other than those required for therapy, serious downstream consequences could result. Bioactivation is also taken into account as being a crucial stage in the action of several medications.

Related Associations:

Associated Journal

Associated Societies

Session 12: Current trends in Clinical Research

Clinical research is a field of medical science that evaluates the efficacy and safety of drugs, equipment, diagnostic tools, and treatment regimens designed for use in people. Clinical practise and clinical research are two distinct things. In clinical research, evidence is gathered to establish a treatment, whereas established treatments are employed in clinical practise.

Related Associations:

Associated Journal

Associated Societies

Session 13: Molecular and Endocrine Pharmacology

The study of bioactive substances at the molecular level is known as Molecular Pharmacology. The knowledge of molecular biology can be used to determine how medications truly work in living things.

Related Associations:

Associated Journal

Associated Societies

Session 14: Role of Pharmacist and Research in hospital

By offering knowledge about medications, pharmacists contribute significantly to the healthcare system. Pharmaceutical therapy's main objective is to improve patients' quality of life while posing the least amount of danger possible by achieving significant results. In order to achieve the desired outcome of patient welfare, pharmacists work to identify illnesses, cure illnesses, eliminate symptoms, limit processes, stop the course of illnesses, and alter physiological mechanisms. A crucial topic in the field of health care is research into pharmacy practise, which focuses on understanding how and why people receive pharmacy services, how much treatment costs, and what happens to patients as a result of this therapy. It aims to promote the use of evidence in decisions about policy and practise made by pharmacists.

Related Associations:

Associated Journal

Associated Societies

Session 15: Bioethics

Bioethics is that the study of the moral issues emerging from advances in biology, medicine, and technologies. It proposes the discussion about moral discernment in society and it's often associated with medical policy and practice, but also to broader questions as environment and well-being. Bioethics is anxious with the moral questions that arise within the relationships among life sciences, biotechnology, medicine, politics, law, theology, and philosophy. It includes the study of values referring to medical care, other branches of medication ("the ethics of the ordinary"), ethical education in science, animal, and environmental ethics.

Related Associations:

Associated Journal

Associated Societies

Session 16: Pharmacokinetics and Pharmacodynamics

Pharmacokinetics is the analysis of drug assimilation, distribution, metabolism, and excretion. The apparent concept in pharmacokinetics is drug clearance, namely, the elimination of drugs from the body. It can be clearly defined as the movement of the drug inside our body. It can describe what changes our body has sustained after taking that drug. Pharmacodynamics is described as how our body responds to the drug. The study of the connection between the concentration of drugs and their effects is known as pharmacodynamics. It is the study of pharmacology that sustains the biochemical and physiological effects of drugs and their conduct in our bodies.

Related Associations:

Associated Journal

Associated Societies

Market Analysis

We kindly invite you to participate in Clinical Pharmacy 2023, a conference that will primarily focus on the most recent developments in toxicology and Pharmacology. The Pharmaceutical industry has undergone a significant transformation as a result of the introduction of technologies with novel, economical, and effective production processes. Additionally, the expansion of investment capital into this industry has a positive effect on market expansion. Artificial intelligence and robotics are utilised to decrease product waste and downtime in workshops (AI). Additionally, open-transfer manufacturing methods have been replaced in the field by single-use solutions. Additionally, precise and error-free production has been achieved as a result of the paradigm shift towards integrated, intelligent, and data-rich paperless operations.

The estimated size of the worldwide Pharmaceutical market in 2020 is 405.52 billion USD. Additionally, there is a possibility that the market would rise rapidly from 2021 to 2028 with a compound annual growth rate of 11.34 percent. With the emergence of new technology as well as profitable and more effective production techniques, the Pharmaceutical industry has experienced a significant transformation. Additionally, the market increase has been favorably impacted by the growing investment flow in this sector. The previous five years saw a tremendous increase in pharmaceutical research. According to market value, growth will reach 40% during the following five years. The main US-based pharmaceutical corporations under investigation include Pfizer, Johnson & Johnson, Merck, Abbott, and others. Companies in the pharmaceutical sector include

Every clinical trial in Austria requires approval from the Federal Office for Safety in Healthcare and the ethics committee's endorsement. The Medicinal Products Act's sections 2a and 28 to 48 provide details on terminological definitions as well as the prerequisites and conduct of clinical studies. The goal is to demonstrate the efficacy and acceptability of various types of treatment and to advance patient care in the future. Clinical trials (intervention studies) and non-interventional investigations are distinguished in concept.

GLOBAL CLINICAL PHARMACY REPORT

Market overview:

The drug discovery market is anticipated to post a CAGR of around 8.21% over the course of the forecast period and generate about USD 58,324.97 million in revenue in 2021. By 2027, it's anticipated to reach 91,107,71 million. The COVID-19 pandemic is causing countries' health systems to spend quickly in R&D to tackle the virus. FDA-approved medicines, molecules undergoing clinical studies, the CHEMBL and ZINC databases, and potential compounds were all searched. Research teams from all over the world are looking for new and existing medications with the potential to treat COVID-19 by testing them for their capacity to reduce symptoms and stop viral replication. The need to find a cure for COVID-19 is therefore anticipated to have a beneficial effect on the drug discovery market because to the ongoing epidemic.

The increasing prevalence of a wide range of ailments (such as cardiovascular and CNS-related disorders), rising Healthcare spending, and the impending patent expiration of blockbuster medications are the driving forces behind the expansion of the drug discovery business. Globally, there is a significant burden from cardiovascular illnesses, infectious diseases, diabetes, and kidney-related problems. Cardiovascular diseases (CVDs) are the main cause of mortality worldwide, accounting for around 32% of all fatalities, according to the World Health Organization's publication of essential statistics on CVDs in June 2021. The leading cause of mortality and disability, CVD continues to be very complicated, expensive, and stressful, according to the article Improving Cardiovascular Drug Development and Evidence Through Patient-Centered Research and Clinical Trials, published in July 2020.

Nevertheless, Pharmaceutical innovation lags behind, and US drug and device clinical trial participation is limited. Additionally, new strategies are needed to streamline and reduce the cost of clinical trials, with a greater focus on patient experience and voice.

According to the American Cancer Society, he will have about 1.8 million new cancer diagnoses in the United States in 2020, and about 606,520 may have died of cancer. Therefore, the increasing burden of various diseases in all age groups and its burden worldwide is driving the demand for drug discovery and its market.

There is an explosion in the use of advanced technologies such as high-throughput, bioinformatics and combinatorial chemistry to better identify drug candidates. Drug discovery has evolved significantly with new technologies, making the process more sophisticated, more precise, and less time consuming. Adoption of artificial intelligence systems in disease diagnosis and treatment design is increasing and is expected to grow steadily in the coming years. For example, on March 31, 2020, Existencia, an AI-based drug discovery company, entered into a collaboration agreement with Diamond Light Source and Scripps Research to identify antiviral therapies for COVID-19. It is expected to contribute to the growth of the market during the forecast period.

Market Analysis of Global Pharmaceutical Industries

The fast-growing division of the Pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and Healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

According to the QuintilesIMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.

The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.

Scope of the Report

According to the scope of the report, Drug Research is the process aimed at identifying therapeutically useful compounds for the treatment and cure of disease. Drug discovery usually begins with molecules that either address biological targets that have been shown to be involved in disease development or have interesting biological activities. In recent times, drug discovery has advanced significantly with new technologies that have made the process more sophisticated, more precise, and less time consuming. The drug discovery market is divided by drug type (small molecule drugs and biologics), technology (high-throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and other technologies), and end users (pharmaceutical companies, contract research organizations (CROs)). ) etc.). end users), Geography (North America, Europe, Asia Pacific, Middle East, Africa, South America). The market report also includes estimated market size and trends for 17 countries in key regions of the world. This report provides the value (Million USD) for the above segment.

What is the market capitalization of a company?

Market capitalization, sometimes referred to the value of a publicly traded company. In most cases, it can be calculated simply by multiplying the stock price by the number of shares outstanding.

Routes of Administration Insights

The oral segment leads the global market with a 2020 valuation of $236.9 billion. Oral dosage forms are affordable, easy to manufacture, and patient-friendly. In addition, advances in drug delivery technology such as B. Sustained-release formulations and targeted drug delivery have made orally administered drugs available at higher levels in the market.

A significant increase in the implementation of automation systems and barrier systems in parenteral manufacturing (including restricted access barrier systems and isolators) is expected to boost the parenteral segment at its fastest CAGR during the forecast period. In addition, the introduction of a wide range of packaging types such as B. Ready-to-fill syringes, cartridges, and vials has greatly changed the field of parenteral manufacturing.

Growing demand for innovative drug delivery systems that are more suited to the 'mobile lifestyle' of patients will pave the way for higher acceptance of pens and auto-injectors, further driving growth in the segment. Additionally, increased outsourcing of fill-finish manufacturing services by drug developers is increasing revenue generation in the parenteral segment.

Key Insights from Primary Research:

As per the analysis shared by our research analyst, the Pharmaceutical market is estimated to grow annually at a CAGR of around 5.70% over the forecast period (2022-2028).

In Terms Of Revenue, The Pharmaceutical market size was valued at around USD 1,482.4 million in 2021 and is projected to reach USD 2,067.36 million by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.1. By Drug Type Analysis, Drugs dominated the market in 2021

By Application analysis, medications for metabolic diseases dominated the sector in 2021
In 2021, North America led the market. This is due to many strategic pharmaceutical alliances, particularly among the region's well-established and early-stage businesses.

PESTEL Analysis for the Pharmaceuticals Market

Current and ongoing changes in political, economic, social, technological, legal and environmental factors influence the growth of the Healthcare market in which pharmaceuticals play a key role. Following factors are boosting the growth of healthcare market:

Reduced taxes and lowered drug prices in the USA
GDP growth of over 6% in China and India
Widespread population aging and sedentary lifestyles leading to increased chronic disease prevalence
Industrialized data services in R&D enabling the use of clinical trial data in trial simulations
Lowered regulatory barriers for new drugs in the USA
High urban pollution levels increasing the incidence of conditions like asthma
As a result, healthcare expenditure per capita is set to rise from its 2017 level of $1137 to $1427 by 2021.

Synapsis:

The Clinical Pharmacy market is anticipated to post a CAGR of around 8.21% over the course of the forecast period and generate about USD 58,324.97 million in revenue in 2021. By 2027, it's anticipated to reach 91,107,71 million. Additionally, the market increase has been favorably impacted by the growing investment flow in this sector. The previous five years saw a tremendous increase in Pharmaceutical research. According to market value, growth will reach 40% during the following five years. The market report also includes estimated market size and trends for 17 countries in key regions of the world. Among all the industrial sectors, the research-based Pharmaceutical science industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

Organizing committee members

Asif Mahmood

Clinical Research and Development, Pharmacy

Pfizer , USA, USA

Zimei Wu, PhD

Associate Professor, Pharamcy

University of Auckland , New Zealand, New Zealand

Nader G. Abraham, Ph.D

Professor, Pharmacy

USA

Dr. Sorush Niknamian, Senior Research Scientist

Senior Research Scientist, Pharmacy

Liberty University, USA, USA

Yazen M Alnouti

Assistant Professor

University of Nebraska Medical Center , USA, USA

Dr. Santosh Kumar

Professor of Pharmaceutical Sciences and Assistant Dean, Pharmacy

University of Tennessee Health Science Center , USA, USA

Zimei Wu, PhD

Associate Professor, Pharamcy

New Zealand

Renowned Speakers

Amir Mohammad Beyzaee, General Physician

Professor, Dermatology

Mazandaran University of medical sciences, Iran

Silvia Stefanelli

lawyer, founder and co-owner of the Studio legale Stefanelli&Stefanelli, healthcare

Studio legale Stefanelli&Stefanelli, Italy

Eslam Mohamed Elnebrisi, MBBS, MSc, PhD, MHPE

Assistant Professor, Department of Pharmacology

Dubai Pharmacy College, UAE, UAE

To Collaborate Scientific Professionals around the World

Conference Date	February 13-15, 2023
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Meena Afzali

University of Greenwich United Kingdom

This was a smaller conference so for me as a young researcher it was a good opportunity to speak. However, there is always room for getting better so would be great to invite more academics and companies for the next conferences. Many thanks

Raymond Compton Jagessar

Jagessar University of Guyana Guyana

The conference was a success despite some participants could not come because of visa issues. Each presenter presented cutting edge research. The food and the hotel hospitable was good

Shraddha S Ghodke

University College London United Kingdom

Thank you very much for the invitation. It was great meeting. very well organised. Good knowledgeable people. I especially liked keynote's and Ennio Caprio’s talk. Good opportunity to network with people from the Pharmaceutics and Nanosc

Smirna Farias

University of Greenwich United Kingdom